UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1743-1751

1998

Volltextzugriff (PDF)

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma

Journal of clinical oncology, 1991-08, Vol.9 (8), p.1403-1408

1991

Volltextzugriff (PDF)

Phase II Trial of Doxorubicin and Docetaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: Eastern Cooperative Oncology Group Study E1196

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2369-2377

2000

Volltextzugriff (PDF)

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer

Annals of oncology, 1996-07, Vol.7 (5), p.465-469

1996

Volltextzugriff (PDF)

Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3828-3834

1999

Volltextzugriff (PDF)

A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus

American journal of clinical oncology, 1998-10, Vol.21 (5), p.462-465

1998

Volltextzugriff (PDF)

Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study

Journal of clinical oncology, 1991-12, Vol.9 (12), p.2153-2161

1991

Volltextzugriff (PDF)

Current treatment options for malignant melanoma

Drugs (New York, N.Y.), 1998-06, Vol.55 (6), p.791-799

1998

Volltextzugriff (PDF)

A Phase II Evaluation of Clofazimine plus Doxorubicin in Advanced, Unresectable Primary Hepatocellular Carcinoma

Oncology, 1999-10, Vol.57 (3), p.232-235

1999

Volltextzugriff (PDF)

Mitomycin C, Epirubicin and Cisplatin versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin

Oncology, 1998-03, Vol.55 (2), p.116-121

1998

Volltextzugriff (PDF)

Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study

Journal of clinical oncology, 1994-01, Vol.12 (1), p.45-49

1994

Volltextzugriff (PDF)

Prognostic Value of Histologic Grade and Proliferative Activity in Axillary Node–Positive Breast Cancer: Results From the Eastern Cooperative Oncology Group Companion Study, EST 4189

Journal of clinical oncology, 2000-05, Vol.18 (10), p.2059-2069

2000

Volltextzugriff (PDF)

Fludarabine : A phase II trial in patients with previously treated low-grade lymphoma

American journal of clinical oncology, 1996-06, Vol.19 (3), p.268-270

FALKSON, C. I

1996

Volltextzugriff (PDF)

Prognostic factors in metastatic malignant melanoma : An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992

Oncology, 1998-01, Vol.55 (1), p.59-64

1998

Volltextzugriff (PDF)

Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin

Oncology, 1996-07, Vol.53 (4), p.313-317

1996

Volltextzugriff (PDF)

21-Day oral etoposide for metastatic breast cancer : A phase II study and review of the literature

American journal of clinical oncology, 2000-06, Vol.23 (3), p.258-262

2000

Volltextzugriff (PDF)

Phase II trial of fotemustine in patients with metastatic malignant melanoma

Investigational new drugs, 1994-01, Vol.12 (3), p.251-254

1994

Volltextzugriff (PDF)

Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma

Medical oncology (Northwood, London, England), 1995-03, Vol.12 (1), p.35-40

FALKSON, C. I

1995

Volltextzugriff (PDF)

Treatment of metastatic malignant melanoma

Anti-cancer drugs, 1995-12, Vol.6 (6), p.709-716

Falkson, Carla Isadora

1995

Volltextzugriff (PDF)

An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma

Investigational new drugs, 1992-11, Vol.10 (4), p.337-343

1992

Volltextzugriff (PDF)

Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer

South African medical journal, 2000-08, Vol.90 (8), p.788-788

2000

Volltextzugriff (PDF)

Extended survival in 80 patients with operable, locoregionally recurrent breast cancer treated with chemotherapy

American journal of clinical oncology, 1998-10, Vol.21 (5), p.501-504

1998

Volltextzugriff (PDF)

Treatment of squamous cell esophageal cancer with topotecan: An Eastern Cooperative Oncology Group Study (E2293)

American journal of clinical oncology, 2000-02, Vol.23 (1), p.45-46

2000

Volltextzugriff (PDF)

A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancer

American journal of clinical oncology, 1993-02, Vol.16 (1), p.14-17

1993

Volltextzugriff (PDF)

High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting

Investigational new drugs, 1990-11, Vol.8 (4), p.407-409

1990

Volltextzugriff (PDF)

1 – 25 von 376

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(325)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(267)
Life Sciences & Biomedicine
(226)
Science & Technology
(226)
Oncology
(200)
Female
(184)
Middle Aged
(138)
Adult
(126)
Aged
(100)
Biological And Medical Sciences
(89)
Breast Neoplasms - Drug Therapy
(89)
Medical Sciences
(88)
Male
(84)
Antineoplastic Agents
(65)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(65)
Chemotherapy
(64)
Pharmacology. Drug Treatments
(64)
Prognosis
(52)
Neoplasm Metastasis
(46)
Drug Therapy, Combination
(41)
Clinical Trials As Topic
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(49)
Cancer Research
(32)
South African Medical Journal
(32)
Cancer
(30)
Journal Of Thoracic Oncology
(26)
American Journal Of Clinical Oncology
(19)
Cancer Treatment Reports
(17)
Annals Of Oncology
(16)
Oncology
(13)
Cancer Chemotherapy Reports. Part 1
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study

Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma

Phase II Trial of Doxorubicin and Docetaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: Eastern Cooperative Oncology Group Study E1196

A randomised study of CGS 16949A (fadrozole) versus tamoxifen in previously untreated postmenopausal patients with metastatic breast cancer

Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study

A randomized study of radiotherapy alone versus radiotherapy plus 5-fluorouracil and platinum in patients with inoperable, locally advanced squamous cancer of the esophagus

Factors predicting for response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study

Current treatment options for malignant melanoma

A Phase II Evaluation of Clofazimine plus Doxorubicin in Advanced, Unresectable Primary Hepatocellular Carcinoma

Mitomycin C, Epirubicin and Cisplatin versus Mitomycin C Alone as Therapy for Carcinoma of Unknown Primary Origin

Reinduction with the same cytostatic treatment in patients with metastatic breast cancer: an Eastern Cooperative Oncology Group study

Prognostic Value of Histologic Grade and Proliferative Activity in Axillary Node–Positive Breast Cancer: Results From the Eastern Cooperative Oncology Group Companion Study, EST 4189

Fludarabine : A phase II trial in patients with previously treated low-grade lymphoma

Prognostic factors in metastatic malignant melanoma : An analysis of 236 patients treated on clinical research studies at the Department of Medical Oncology, University of Pretoria, South Africa from 1972-1992

Cisplatin versus cisplatin plus D-Trp-6-LHRH in the treatment of ovarian cancer: a pilot trial to investigate the effect of the addition of a GnRH analogue to cisplatin

21-Day oral etoposide for metastatic breast cancer : A phase II study and review of the literature

Phase II trial of fotemustine in patients with metastatic malignant melanoma

Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma

Treatment of metastatic malignant melanoma

An extended phase II trial of ifosfamide plus mesna in malignant mesothelioma

Absence of commonly recurring BRCA1 mutations in black South African women with breast cancer

Extended survival in 80 patients with operable, locoregionally recurrent breast cancer treated with chemotherapy

Treatment of squamous cell esophageal cancer with topotecan: An Eastern Cooperative Oncology Group Study (E2293)

A randomized trial of mitomycin-C (M) versus mitomycin-C plus high-dose medroxyprogesterone acetate (MMPA) in the treatment of patients with advanced breast cancer

High versus low dose granisetron, a selective 5HT3 antagonist, for the prevention of chemotherapy-induced nausea and vomiting

Suchergebnisse filtern